-
CYTH Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cyclo Therapeutics (CYTH)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 928.01 k | 928.01 k | 928.01 k | 928.01 k | 928.01 k | 928.01 k |
Cash burn (monthly) | 64.60 k | 72.83 k | 2.94 mm | 2.13 mm | 2.73 mm | 1.88 mm |
Cash used (since last report) | 260.33 k | 293.51 k | 11.87 mm | 8.59 mm | 11.00 mm | 7.56 mm |
Cash remaining | 667.68 k | 634.50 k | -10.94 mm | -7.66 mm | -10.08 mm | -6.63 mm |
Runway (months of cash) | 10.3 | 8.7 | -3.7 | -3.6 | -3.7 | -3.5 |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 1 |
Closed positions | 16 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 1.32 bn |
Total shares | 14.02 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
RFL Rafael | 12.78 mm | $12.03 mm |
EPIQ Capital | 817.27 k | $1.04 bn |
Hirschman Orin | 209.38 k | $2.79 mm |
Geode Capital Management | 175.42 k | $222.84 mm |
Wealth Enhancement Advisory Services | 20.40 k | $25.91 mm |
Renaissance Technologies | 13.36 k | $16.96 mm |
Steward Partners Investment Advisory | 90.00 | $114.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Dec 24 | Rafael | Common Stock | Conversion | Acquire C | No | No | 0.63 | 3,968,254 | 2.50 mm | 12,998,194 |
15 Nov 24 | Toig Randall M. | Common Stock | Grant | Acquire A | No | No | 0 | 20,067 | 0.00 | 145,826 |
15 Nov 24 | Cross Shawn | Common Stock | Grant | Acquire A | No | No | 0 | 17,228 | 0.00 | 107,749 |
15 Nov 24 | William Conkling | Common Stock | Grant | Acquire A | No | No | 0 | 16,660 | 0.00 | 50,230 |
15 Nov 24 | Strattan Ce Rick | Common Stock | Grant | Acquire A | No | No | 0 | 63,608 | 0.00 | 369,103 |